Have you registered for #ASGCT2025? Secure your spot to join us in New Orleans or virtually at the for the premier event in gene and cell therapy.
The webinars in this series are designed to inform patients, patient advocates, families, and the public about various aspects of gene therapy.
The third in a series of five educational webinars from ASGCT and the National Organization for Rare Disorders (NORD), is now available to watch for free.
Download the Slides Here
This session, held on Oct. 30, explores regulatory pathways for gene therapies, how gene therapies are deemed safe, and more. Speakers include Peter Marks, M.D., Ph.D., director of the FDA's Center for Biologics Evaluation and Research (CBER); and Julie Tierney, J.D., senior policy advisory for strategic planning and legislation at CBER. To learn more about the FDA's role in the process of developing gene therapies, visit our Patient Education portal.
Mark your calendar for the rest of the sessions in this free webinar series. All the webinars are designed to inform patients, patient advocates, families, and the public about various aspects of gene therapy.
If you missed the first two webinars, you can watch “Gene Therapy: Yesterday, Today and Tomorrow” here, and "The Science Behind Gene Therapy" here.
May 13-17, 2025 | New Orleans
© 2000-2025 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico